COP vs JNJ: Which Is the Better Buy?
Side-by-side comparison of ConocoPhillips and Johnson & Johnson — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
ConocoPhillips · Energy
$127.53
+32.1% upside to fair value
Med Conviction
Grade B
VS
Johnson & Johnson · Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
COP has more upside to fair value
(+32.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
COP |
JNJ |
| Current Price |
$127.53 |
$270.68 |
| Fair Value Estimate |
$168.50 |
$286.05 |
| Upside to Fair Value |
+32.1%
|
+5.7%
|
| Market Cap |
$155.4B |
$652.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
6.2x
|
20.2x
|
| Price / Sales |
2.5x
|
6.7x
|
| Price / FCF |
7.9x
|
35.3x
|
| Revenue Growth YoY |
+36.8%
|
+6.6%
|
| Gross Margin |
27.7%
|
67.9%
|
| Operating Margin |
21.9%
|
26.8%
|
| Return on Equity |
14.3%
|
25.7%
|
| Dividend Yield |
2.63% |
1.95% |
| FCF Yield |
12.66%
|
2.83%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
ConocoPhillips is a global exploration and production company with a portfolio spanning unconventional North American shale, conventional international assets, LNG ventures, and Canadian oil sands, run by a new leadership team after Andy O'Brien became CEO on September 1, 2026. The business quality is medium: it generates substantial cash, with $16.15 in free cash flow per share and a 14.3% retur…
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:…
Accumulation Zones
| Metric |
COP |
JNJ |
| Zone Low |
$126.38 |
$214.54 |
| Zone High |
$143.22 |
$243.14 |
| In Buy Zone? |
Yes
|
No
|